http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009071094-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcec48184185242b877f83500500839a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5b356360a54d9baf302b93d21f700ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a2194d072b5fa2982773bef4eab9d24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2008-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd10c2ae1da1e0b56b969b4e42da6f02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826beb6b0ff8606f682fcbb791419d2a
publicationDate 2009-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009071094-A3
titleOfInvention Combination treatment of ischemic effects
abstract The present invention relates to the induction of hypothermia in humans, male and female, at any age, in a predictable and dose responsive fashion by use of a pharmaceutical composition comprising a combination of two or more compounds selected among (1) vanilloid receptor agonists, capsaicinoids or capsaicinoid-like agonists reaching and binding to vanilloid receptors, and (2) cannabinoids or cannabimimetic agonists reaching and binding to cannabinoid receptors, and (3) adenosine receptor agonists, and (4) neurotensin receptor agonists, and (5) thyroxine derivatives, and (6) cytochrome c inhibitors, and (7) oxygen tension reducers, with the proviso that if the first compound is (1) then the second is not (2), thereby inducing hypothermia, thus benefiting patients suffering from illnesses characterized by tissue anoxia.
priorityDate 2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008040361-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004102368-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007082309-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686

Total number of triples: 24.